Company News, Regulations

FDA Sends Warning Letter To Contract Manufacturer

Mexican firm flagged by agency works with Markwins.

The US FDA has sent a warning letter to Baja Fur S.A. de C.V./Markwins Beauty Brands, Inc. following the inspection of Baja Fur's Tijuana, Mexico facility where Markwins Beauty Brands, Inc. conducts and oversees drug manufacturing operations. The warning letter summarizes significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. See Title 21 Code of Federal Regulations (CFR), parts 210 and 211 (21 CFR parts 210 and 211). The inspe...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters